ZymoGenetics (English Wikipedia)

"Novo Nordisk completes divestment of ZymoGenetics, Inc". Bionity.com. 13 October 2010. Archived from the original on May 18, 2020. Retrieved 21 May 2015. Novo Nordisk has been a shareholder of ZymoGenetics since 1988 and at the time of the transaction, Novo Nordisk owned 22,143,320 shares, equalling close to 26% of the share capital.

bms.com (Global: low place; English: low place)

"ZymoGenetics, a Bristol-Myers Squibb Company". Bristol-Myers Squibb. Archived from the original on March 22, 2017. Retrieved 21 May 2015.

fiercebiotech.com (Global: low place; English: 8,828^th place)

Carroll, John (8 September 2010). "BMS forges $885M deal to buy ZymoGenetics". FierceBiotech. Archived from the original on May 18, 2020. Retrieved 21 May 2015. Bristol-Myers Squibb has struck a deal to buy Seattle-based ZymoGenetics for $885 million.

geekwire.com (Global: 4,157^th place; English: 2,583^rd place)

McGrane, Clare (November 1, 2018). "Bristol-Myers Squibb will close its Seattle Zymogenetics operations next year". GeekWire. Archived from the original on May 18, 2020.

nytimes.com (Global: 7^th place; English: 7^th place)

Pollack, Andrew (23 October 2000). "ZymoGenetics Will Become Independent of Novo Nordisk". The New York Times. Archived from the original on May 18, 2020. Retrieved 21 May 2015. ZymoGenetics Inc. said it had arranged for $150 million in private financing that would allow it to become independent of its parent company, Novo Nordisk A.S. of Denmark.
"Focus: Seattle; Transforming a Rundown Lake Shoreline (Published 1993)". 1993-07-04. Retrieved 2023-08-13.

pharmalive.com (Global: low place; English: low place)

Slatko, Joshua (December 2013). "BMS changes senior management team" (PDF). People on the Move: Biopharma. Med Ad News. Vol. 32, no. 12. p. 27. ISSN 1067-733X. Archived (PDF) from the original on May 18, 2020.

seattletimes.com (Global: 519^th place; English: 316^th place)

Romano, Benjamin (November 1, 2018). "Seattle biotech stalwart ZymoGenetics prepares for year-end closure". The Seattle Times. Archived from the original on May 18, 2020.
"Bristol-Myers Squibb buying ZymoGenetics". September 7, 2010. Archived from the original on May 18, 2020.
Romano, Benjamin (June 15, 2018). "The Hutch's 30-year journey to the Lake Union steam plant". The Seattle Times. Archived from the original on May 18, 2020.
Lerman, Rachel (December 14, 2016). "ZymoGenetics won't renew South Lake Union lease". The Seattle Times. Archived from the original on May 18, 2020.
Romano, Benjamin (June 11, 2018). "Hutch cancer center will put labs in Seattle's historic Lake Union steam plant". The Seattle Times. Archived from the original on May 18, 2020.
Erb, George (August 1, 2017). "Seattle Genetics buys biotech factory in Bothell". The Seattle Times. Archived from the original on May 18, 2020.

web.archive.org (Global: 1^st place; English: 1^st place)

Pollack, Andrew (23 October 2000). "ZymoGenetics Will Become Independent of Novo Nordisk". The New York Times. Archived from the original on May 18, 2020. Retrieved 21 May 2015. ZymoGenetics Inc. said it had arranged for $150 million in private financing that would allow it to become independent of its parent company, Novo Nordisk A.S. of Denmark.
"ZymoGenetics, a Bristol-Myers Squibb Company". Bristol-Myers Squibb. Archived from the original on March 22, 2017. Retrieved 21 May 2015.
McGrane, Clare (November 1, 2018). "Bristol-Myers Squibb will close its Seattle Zymogenetics operations next year". GeekWire. Archived from the original on May 18, 2020.
Romano, Benjamin (November 1, 2018). "Seattle biotech stalwart ZymoGenetics prepares for year-end closure". The Seattle Times. Archived from the original on May 18, 2020.
Timmerman, Luke (25 January 2011). "Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers". Xconomy. Archived from the original on May 18, 2020. Retrieved 21 May 2015. ZymoGenetics, the venerable biotech founded in 1981.
"Novo Nordisk completes divestment of ZymoGenetics, Inc". Bionity.com. 13 October 2010. Archived from the original on May 18, 2020. Retrieved 21 May 2015. Novo Nordisk has been a shareholder of ZymoGenetics since 1988 and at the time of the transaction, Novo Nordisk owned 22,143,320 shares, equalling close to 26% of the share capital.
Carroll, John (8 September 2010). "BMS forges $885M deal to buy ZymoGenetics". FierceBiotech. Archived from the original on May 18, 2020. Retrieved 21 May 2015. Bristol-Myers Squibb has struck a deal to buy Seattle-based ZymoGenetics for $885 million.
"Bristol-Myers Squibb buying ZymoGenetics". September 7, 2010. Archived from the original on May 18, 2020.
Timmerman, Luke (13 September 2010). "What Will Happen to ZymoGenetics' Landmark Headquarters when Bristol Calls the Shots?". Xconomy. Archived from the original on May 18, 2020. Retrieved 21 May 2015.
Romano, Benjamin (June 15, 2018). "The Hutch's 30-year journey to the Lake Union steam plant". The Seattle Times. Archived from the original on May 18, 2020.
Lerman, Rachel (December 14, 2016). "ZymoGenetics won't renew South Lake Union lease". The Seattle Times. Archived from the original on May 18, 2020.
Romano, Benjamin (June 11, 2018). "Hutch cancer center will put labs in Seattle's historic Lake Union steam plant". The Seattle Times. Archived from the original on May 18, 2020.
Erb, George (August 1, 2017). "Seattle Genetics buys biotech factory in Bothell". The Seattle Times. Archived from the original on May 18, 2020.
Slatko, Joshua (December 2013). "BMS changes senior management team" (PDF). People on the Move: Biopharma. Med Ad News. Vol. 32, no. 12. p. 27. ISSN 1067-733X. Archived (PDF) from the original on May 18, 2020.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Slatko, Joshua (December 2013). "BMS changes senior management team" (PDF). People on the Move: Biopharma. Med Ad News. Vol. 32, no. 12. p. 27. ISSN 1067-733X. Archived (PDF) from the original on May 18, 2020.

wrfseattle.org (Global: low place; English: low place)

"In Remembrance: Dr. Benjamin D. Hall (1932-2019)". Washington Research Foundation. Retrieved 2023-08-13.

xconomy.com (Global: low place; English: 6,978^th place)

Timmerman, Luke (25 January 2011). "Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers". Xconomy. Archived from the original on May 18, 2020. Retrieved 21 May 2015. ZymoGenetics, the venerable biotech founded in 1981.
Timmerman, Luke (13 September 2010). "What Will Happen to ZymoGenetics' Landmark Headquarters when Bristol Calls the Shots?". Xconomy. Archived from the original on May 18, 2020. Retrieved 21 May 2015.

youtube.com (Global: 9^th place; English: 13^th place)

Dr. Ben Hall - November 1, 2011, retrieved 2023-09-13

ZymoGenetics (English Wikipedia)

bionity.com (Global: low place; English: low place)

bms.com (Global: low place; English: low place)

fiercebiotech.com (Global: low place; English: 8,828th place)

geekwire.com (Global: 4,157th place; English: 2,583rd place)

nytimes.com (Global: 7th place; English: 7th place)

pharmalive.com (Global: low place; English: low place)

seattletimes.com (Global: 519th place; English: 316th place)

web.archive.org (Global: 1st place; English: 1st place)

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

wrfseattle.org (Global: low place; English: low place)

xconomy.com (Global: low place; English: 6,978th place)

youtube.com (Global: 9th place; English: 13th place)

fiercebiotech.com (Global: low place; English: 8,828^th place)

geekwire.com (Global: 4,157^th place; English: 2,583^rd place)

nytimes.com (Global: 7^th place; English: 7^th place)

seattletimes.com (Global: 519^th place; English: 316^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 5^th place; English: 5^th place)

xconomy.com (Global: low place; English: 6,978^th place)

youtube.com (Global: 9^th place; English: 13^th place)